HLB PANAGENE's latest marketcap:
As of 08/31/2026, HLB PANAGENE's market capitalization has reached $37.05 M. According to our data, HLB PANAGENE is the 33461th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 37.05 M |
| Revenue (ttm) | 10.75 M |
| Net Income (ttm) | -2,396,117.28 |
| Shares Out | 45.53 M |
| EPS (ttm) | -0.05 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/29/2004 |
| Earnings Date | 11/13/2026 |
HLB PANAGENE's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/31/2026 | ₩50.67 B | $37.05 M | -16.37% | 33461 |
| 12/30/2025 | ₩78.94 B | $53.64 M | -34.15% | 26000 |
| 12/30/2024 | ₩119.87 B | $80.31 M | -29.22% | 24737 |
| 12/28/2023 | ₩169.35 B | $130.4 M | 24.28% | 21371 |
| 12/29/2022 | ₩136.26 B | $107.64 M | 11.73% | 21808 |
| 12/30/2021 | ₩121.96 B | $102.45 M | -11.85% | 22963 |
| 12/30/2020 | ₩138.35 B | $0 | 83.58% | 19234 |
| 12/30/2019 | ₩75.36 B | $64.81 M | -48.24% | 20445 |
| 12/28/2018 | ₩145.6 B | $129.58 M | -46.25% | 15981 |
| 12/28/2017 | ₩270.87 B | $251.91 M | 33.8% | 13614 |
Company Profile
About HLB PANAGENE Co., LTD.
HLB PANAGENE Co., LTD. is a South Korean company specializing in molecular diagnostics. The company develops innovative diagnostic products for various cancers and diseases, leveraging advanced biotechnology solutions.
Key Products & Services
- Liquid Biopsy Products: Designed for lung and colon cancers.
- Tissue Biopsy Products: Covering lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system disorders, myelofibrosis, and polycythemia vera.
- Diagnostic Solutions: For cervical cancer, sexually transmitted diseases, and extreme drug resistance conditions.
- Peptide Nucleic Acid (PNA) Products: Advanced molecular tools for research and diagnostics.
Company Background
Originally established as Panagene Inc., the company rebranded to HLB PANAGENE Co., LTD. in August 2023. Founded in 1976, it is headquartered in Daejeon, South Korea.
Frequently Asked Questions
-
What is HLB PANAGENE's (KOSDAQ-046210) current market cap?As of 08/31/2026, HLB PANAGENE (including the parent company, if applicable) has an estimated market capitalization of $37.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does HLB PANAGENE (KOSDAQ-046210) rank globally by market cap?HLB PANAGENE global market capitalization ranking is approximately 33461 as of 08/31/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.